What is your e-mail address?

My e-mail address is:

Do you have a password?

Forgot your password? Click here
close

In Pursuit of the Paperless Clinical Trial: A look at EDC and CTMS

Jul 02, 2008

The cost of developing a drug is reaching astronomical levels, and the life science industry is looking to cut costs wherever possible. Therefore, company executives are turning their attention to improving inefficiencies during the most expensive phase of drug development clinical trials. This report will analyze software solutions developed to streamline the clinical research process.

Introduction
The cost of developing a drug is reaching astronomical levels, and the life science industry is looking to cut costs wherever possible. Therefore, company executives are turning their attention to improving inefficiencies during the most expensive phase of drug development clinical trials. This report will analyze software solutions developed to streamline the clinical research process.

Scope
Identifies the key forces driving the adoption of eClinical technology solutions
Analyzes the crucial issues that will impede the uptake of clinical research tools
Discusses the key functionalities needed for a complete eClinical solution
Offers insight into how IT vendors can improve their products and evaluates key vendors in the market


Report Highlights
With costs skyrocketing, companies are turning to computerized systems and IT solutions to increase productivity and maximize the efficiency of clinical trials. The adoption of EDC and CTMS solutions will be integral in enhancing and transforming the data collection and management aspects of a trial.

To fully leverage the benefits of these technologies, eClinical solutions must be built on an interoperable framework that will enable life science companies to run clinical trials in a more efficient manner since many redundancies which currently exist in the point solutions will be eliminated.

Until all stakeholders in the clinical trial process are educated on the true features and benefits of modern clinical technologies and are willing to make the necessary mental and cultural switch, adoption of eClinical solutions will remain sluggish. Vendors should take this opportunity to partner with companies to enhance the research process.


Nick Wakeman

Nick Wakeman's Business Beat